MTHFD2 and cancer: Therefore, in conclusion, MTHFD2 is to some extent oncogenic, which could be considered a therapeutic target and prognostic indicator for cancer, and future research directions should profoundly elucidate the mechanism of its promotion of cancer progression and accelerate the progress of functional inhibitors [177–179].